BORIS/CTCFL-mediated transcriptional regulation of the hTERT telomerase gene in testicular and ovarian tumor cells

Telomerase activity, not detectable in somatic cells but frequently activated during carcinogenesis, confers immortality to tumors. Mechanisms governing expression of the catalytic subunit hTERT, the limiting factor for telomerase activity, still remain unclear. We previously proposed a model in which the binding of the transcription factor CTCF to the two first exons of hTERT results in transcriptional inhibition in normal cells. This inhibition is abrogated, however, by methylation of CTCF binding sites in 85% of tumors. Here, we showed that hTERT was unmethylated in testicular and ovarian tumors and in derivative cell lines. We demonstrated that CTCF and its paralogue, BORIS/CTCFL, were both present in the nucleus of the same cancer cells and bound to the first exon of hTERT in vivo. Moreover, exogenous BORIS expression in normal BORIS-negative cells was sufficient to activate hTERT transcription with an increasing number of cell passages. Thus, expression of BORIS was sufficient to allow hTERT transcription in normal cells and to counteract the inhibitory effect of CTCF in testicular and ovarian tumor cells. These results define an important contribution of BORIS to immortalization during tumorigenesis.

[1]  G. Kroemer,et al.  hTERT: a novel endogenous inhibitor of the mitochondrial cell death pathway , 2013, Oncogene.

[2]  T. Tollefsbol,et al.  Sulforaphane Causes Epigenetic Repression of hTERT Expression in Human Breast Cancer Cell Lines , 2010, PloS one.

[3]  Victor V Lobanenkov,et al.  Expression of a Testis-Specific Form of Gal3st1 (CST), a Gene Essential for Spermatogenesis, Is Regulated by the CTCF Paralogous Gene BORIS , 2010, Molecular and Cellular Biology.

[4]  D. Loukinov,et al.  PAX5 activates the transcription of the human telomerase reverse transcriptase gene in B cells , 2010, The Journal of pathology.

[5]  Soo-Hyun Park,et al.  TSA-induced DNMT1 down-regulation represses hTERT expression via recruiting CTCF into demethylated core promoter region of hTERT in HCT116. , 2010, Biochemical and biophysical research communications.

[6]  Steven S. Chang,et al.  Coordinated Activation of Candidate Proto-Oncogenes and Cancer Testes Antigens via Promoter Demethylation in Head and Neck Cancer and Lung Cancer , 2009, PloS one.

[7]  Megan Hitchins,et al.  Differential expression of the embryo/cancer gene ECSA(DPPA2), the cancer/testis gene BORIS and the pluripotency structural gene OCT4, in human preimplantation development. , 2008, Molecular human reproduction.

[8]  T. Ichim,et al.  Selective apoptosis of breast cancer cells by siRNA targeting of BORIS. , 2008, Biochemical and biophysical research communications.

[9]  A. Feinberg,et al.  DNA methyltransferase 1 and 3B activate BAG-1 expression via recruitment of CTCFL/BORIS and modulation of promoter histone methylation. , 2008, Cancer research.

[10]  Victor V Lobanenkov,et al.  BORIS, a paralogue of the transcription factor, CTCF, is aberrantly expressed in breast tumours , 2008, British Journal of Cancer.

[11]  V. Noskov,et al.  Evolutionary Diversification of SPANX-N Sperm Protein Gene Structure and Expression , 2007, PloS one.

[12]  Victor V Lobanenkov,et al.  Dual role of DNA methylation inside and outside of CTCF-binding regions in the transcriptional regulation of the telomerase hTERT gene , 2007, Nucleic acids research.

[13]  Victor V Lobanenkov,et al.  Elicitation of T Cell Responses to Histologically Unrelated Tumors by Immunization with the Novel Cancer-Testis Antigen, Brother of the Regulator of Imprinted Sites1 , 2007, The Journal of Immunology.

[14]  K. Odunsi,et al.  DNA methylation-dependent regulation of BORIS/CTCFL expression in ovarian cancer. , 2007, Cancer immunity.

[15]  J. Herman,et al.  hTERT is expressed in cancer cell lines despite promoter DNA methylation by preservation of unmethylated DNA and active chromatin around the transcription start site. , 2007, Cancer research.

[16]  P. Jelinic,et al.  The Testis-Specific Factor CTCFL Cooperates with the Protein Methyltransferase PRMT7 in H19 Imprinting Control Region Methylation , 2006, PLoS biology.

[17]  Victor V Lobanenkov,et al.  Antitumor efficacy of DNA vaccination to the epigenetically acting tumor promoting transcription factor BORIS and CD80 molecular adjuvant , 2006, Journal of cellular biochemistry.

[18]  F. Recillas-Targa,et al.  Epigenetic boundaries of tumour suppressor gene promoters: the CTCF connection and its role in carcinogenesis , 2006, Journal of cellular and molecular medicine.

[19]  G. Kroemer,et al.  hTERT: a novel endogenous inhibitor of the mitochondrial cell death pathway , 2006, Oncogene.

[20]  D. Loukinov,et al.  CTCF binds the proximal exonic region of hTERT and inhibits its transcription , 2005, Nucleic acids research.

[21]  Victor V Lobanenkov,et al.  Conditional expression of the CTCF-paralogous transcriptional factor BORIS in normal cells results in demethylation and derepression of MAGE-A1 and reactivation of other cancer-testis genes. , 2005, Cancer research.

[22]  Victor V Lobanenkov,et al.  Reciprocal binding of CTCF and BORIS to the NY-ESO-1 promoter coincides with derepression of this cancer-testis gene in lung cancer cells. , 2005, Cancer research.

[23]  Victor V Lobanenkov,et al.  Familial cases of point mutations in the XIST promoter reveal a correlation between CTCF binding and pre-emptive choices of X chromosome inactivation. , 2005, Human molecular genetics.

[24]  Rolf Ohlsson,et al.  CTCF is conserved from Drosophila to humans and confers enhancer blocking of the Fab‐8 insulator , 2005, EMBO reports.

[25]  J. Benhattar,et al.  Unusual distribution of DNA methylation within the hTERT CpG island in tissues and cell lines. , 2004, Biochemical and biophysical research communications.

[26]  A. Smogorzewska,et al.  Regulation of telomerase by telomeric proteins. , 2004, Annual review of biochemistry.

[27]  M. Widschwendter,et al.  Methylation status and expression of human telomerase reverse transcriptase in ovarian and cervical cancer. , 2004, Gynecologic oncology.

[28]  M. Kang,et al.  Hypermethylation of the hTERT promoter inhibits the expression of telomerase activity in normal oral fibroblasts and senescent normal oral keratinocytes , 2003, British Journal of Cancer.

[29]  J. Benhattar,et al.  Demethylation of the human telomerase catalytic subunit (hTERT) gene promoter reduced hTERT expression and telomerase activity and shortened telomeres. , 2003, Experimental cell research.

[30]  T. Tollefsbol,et al.  Control mechanisms in the regulation of telomerase reverse transcriptase expression in differentiating human teratocarcinoma cells. , 2003, Biochemical and biophysical research communications.

[31]  J. Davie,et al.  The many roles of the transcriptional regulator CTCF. , 2003, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[32]  F. Bosman,et al.  Implication of the exon region in the regulation of the human telomerase reverse transcriptase gene promoter. , 2003, Biochemical and biophysical research communications.

[33]  Victor V Lobanenkov,et al.  The novel BORIS + CTCF gene family is uniquely involved in the epigenetics of normal biology and cancer. , 2002, Seminars in cancer biology.

[34]  F. Bosman,et al.  Hypermethylation of the human telomerase catalytic subunit (hTERT) gene correlates with telomerase activity , 2002, International journal of cancer.

[35]  J. J. Breen,et al.  BORIS, a novel male germ-line-specific protein associated with epigenetic reprogramming events, shares the same 11-zinc-finger domain with CTCF, the insulator protein involved in reading imprinting marks in the soma , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[36]  T. Kakizoe,et al.  Methylation status and expression of human telomerase reverse transcriptase mRNA in relation to hypermethylation of the p16 gene in colorectal cancers as analyzed by bisulfite PCR-SSCP. , 2002, Japanese journal of clinical oncology.

[37]  W. Eisterer,et al.  CpG island methylation of the hTERT promoter is associated with lower telomerase activity in B-cell lymphocytic leukemia. , 2002, Experimental hematology.

[38]  R Ohlsson,et al.  CTCF is a uniquely versatile transcription regulator linked to epigenetics and disease. , 2001, Trends in genetics : TIG.

[39]  M. Hande,et al.  The telomerase reverse transcriptase is limiting and necessary for telomerase function in vivo , 2000, Current Biology.

[40]  T. Kouzarides,et al.  Transcriptional repression by the insulator protein CTCF involves histone deacetylases. , 2000, Nucleic acids research.

[41]  R. Weinberg,et al.  Methylation of the human telomerase gene CpG island. , 2000, Cancer research.

[42]  J. Barrett,et al.  DNA methylation analysis of the promoter region of the human telomerase reverse transcriptase (hTERT) gene. , 1999, Cancer research.

[43]  G. Hagen,et al.  Genomic organization and promoter characterization of the gene encoding the human telomerase reverse transcriptase (hTERT). , 1999, Gene.

[44]  J. Barrett,et al.  Cloning and characterization of the promoter region of human telomerase reverse transcriptase gene. , 1999, Cancer research.

[45]  M. Yutsudo,et al.  Cloning of human telomerase catalytic subunit (hTERT) gene promoter and identification of proximal core promoter sequences essential for transcriptional activation in immortalized and cancer cells. , 1999, Cancer research.

[46]  Y. Cong,et al.  The human telomerase catalytic subunit hTERT: organization of the gene and characterization of the promoter. , 1999, Human molecular genetics.

[47]  R. Weinberg,et al.  Telomerase activity is restored in human cells by ectopic expression of hTERT (hEST2), the catalytic subunit of telomerase , 1998, Oncogene.

[48]  C. Harley,et al.  Extension of life-span by introduction of telomerase into normal human cells. , 1998, Science.

[49]  E. Blackburn.  The telomere and telomerase: nucleic acid-protein complexes acting in a telomere homeostasis system. A review. , 1997, Biochemistry. Biokhimiia.

[50]  June Corwin,et al.  Telomerase Catalytic Subunit Homologs from Fission Yeast and Human , 1997 .

[51]  Gregg B. Morin,et al.  Reconstitution of human telomerase with the template RNA component hTR and the catalytic protein subunit hTRT , 1997, Nature Genetics.

[52]  T. Ide,et al.  Telomerase activity in normal human epithelial cells. , 1996, Oncogene.

[53]  C. Greider,et al.  Telomere length regulation. , 1996, Annual review of biochemistry.

[54]  et al.,et al.  The RNA component of human telomerase , 1995, Science.

[55]  C B Harley,et al.  Specific association of human telomerase activity with immortal cells and cancer. , 1994, Science.

[56]  Robert C. Wolpert,et al.  A Review of the , 1985 .